Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from Mayne Pharma Group ( (AU:MYX) ).
Mitsubishi UFJ Financial Group, Inc. has made changes in its substantial holding in Mayne Pharma Group Limited. The notice indicates a shift in the voting power and relevant interests of Mitsubishi UFJ Financial Group, Inc., reflecting a decrease in their voting power from 6.61% to 5.19%. This change in holdings and voting power may have implications for the company’s influence and decision-making within Mayne Pharma Group Limited.
The most recent analyst rating on (AU:MYX) stock is a Buy with a A$7.09 price target. To see the full list of analyst forecasts on Mayne Pharma Group stock, see the AU:MYX Stock Forecast page.
More about Mayne Pharma Group
Average Trading Volume: 962,966
Technical Sentiment Signal: Sell
Current Market Cap: A$412.7M
Learn more about MYX stock on TipRanks’ Stock Analysis page.